Piam, a pharmaceutical company, completed the acquisition of Bruschettini Farmaceutici, a developer and manufacturer of respiratory, primary care, ophthalmic pharmaceutical, and medical device products. Financial terms were not disclosed. “This milestone will be only the first turning point towards new growth horizons based on three fundamental pillars: proprietary products developed by Piam and Bruschettini; ongoing industrial partnerships; the consolidated relationship with international distributors operating, in particular, in China, Asia and the Pacific "; the two companies, while remaining distinct and based on their experience, undertake together a "single strategic path that will lead them to new growth goals in the future, thanks to the ability to respond promptly to the opportunities of the Italian and international market," Andrea Maini, PIAM CEO.